- Home
- Products
- Customized ADCs
- IL13RA2
- Anti-IL13RA2 (clone hu08)-Mc- ADC
Anti-IL13RA2 (clone hu08)-Mc- ADC (CAT#: ADC-W-010)
This ADC product is comprised of an anti- IL13RA2 monoclonal antibody (clone hu08) conjugated via a Mc linker to a drug.
- Product Information
- ADC Target
- ADC Antibody
- ADC Linker
- Antibody clone #
- hu08
- Name
- IL13RA2
- Alternative Names
- CT19; IL-13R; IL13BP; CD213A2
- Target Entrez Gene ID
- 3598
- Target UniProt ID
- Q14627
- Overview
- The protein encoded by this gene is closely related to Il13RA1, a subuint of the interleukin 13 receptor complex. This protein binds IL13 with high affinity, but lacks cytoplasmic domain, and does not appear to function as a signal mediator. It is reported to play a role in the internalization of IL13.
- Overview
- Humanized Anti-IL13RA2 antibody, clone # hu08
- Clone #
- hu08
- Species Reactivity
- Human
- Name
- Mc (maleimidocaproyl)
- Description
- Noncleavable linkers, is considered noncleavable-meaning linker cleavage, and payload release does not depend on the differential properties between the plasma and some cytoplasmic compartments. Instead, the release of the cytotoxic drug is postulated to occur after internalization of the ADC via antigen-mediated endocytosis and delivery to lysosomal compartment, where the antibody is degraded to the level of amino acids through intracellular proteolytic degradation.
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-MUC1 (clone ch3A5)-Mc-MMAF ADC (CAT#: ADC-W-240)
- Anti-PCSK9 (Ralpancizumab)-SMCC-DM1 ADC (CAT#: ADC-W-2312)
- Anti-GUCY2C (clone 5F9)-Mc-MMAF ADC (CAT#: ADC-W-210)
- Anti-GPC3 (Codrituzumab)-MC-Vc-PAB-MMAE ADC (CAT#: ADC-W-2321)
- Anti-CD22-Mc-VC-PAB-NMS249 ADC (CAT#: ADC-W-540)
- Anti-CD44 (Bivatuzumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (CAT#: ADC-W-2547)
- Anti-ERBB2 (Margetuximab)-SMCC-DM1 ADC (CAT#: ADC-W-1106)
- Anti-CD200 (Samalizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (CAT#: ADC-W-793)
- Anti-ICAM1 (Enlimomab)-SMCC-DM1 ADC (CAT#: ADC-W-1208)
- Anti-IL2RA (Daclizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (CAT#: ADC-W-1375)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for ADC-W-010. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
Same Linker
| CAT# | Product Name | Linker | Payload |
| ADC-W-009 | Anti-IL13RA2 (clone hu08)-MalPeg ADC | MalPeg |
| CAT# | Product Name | Linker | Payload |
| ADC-W-478 | Anti-ENPP3-Mc-MMAF ADC | Mc (maleimidocaproyl) | MMAF (Monomethyl auristatin F) |
| ADC-W-485 | Anti-EphA2 (clone 1C1)-Mc-MMAF ADC | Mc (maleimidocaproyl) | MMAF (Monomethyl auristatin F) |
| ADC-W-2612 | Anti-MS4A1 (Rituximab)-MC-MMAF ADC | MC (maleimidocaproyl) | MMAF |
| ADC-W-452 | Anti-CD70 (clone 1F6)-Mc-MMAF ADC | Mc (maleimidocaproyl) | MMAF (Monomethyl auristatin F) |
| ADC-W-491 | Anti-TNFRSF17-Mc-MMAF ADC | Mc (maleimidocaproyl) | MMAF (Monomethyl auristatin F) |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
